Grading System Used for AASLD-IDSA Hepatitis C Guidance
Classification | Description |
---|
Class I | Conditions for which there is evidence and/or general agreement that a given diagnostic evaluation, procedure, or treatment is beneficial, useful, and effective |
Class II | Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness and efficacy of a diagnostic evaluation, procedure, or treatment |
Class IIa | Weight of evidence and/or opinion is in favor of usefulness and efficacy |
Class IIb | Usefulness and efficacy are less well established by evidence and/or opinion |
Class III | Conditions for which there is evidence and/or general agreement that a diagnostic evaluation, procedure, or treatment is not useful and effective or if it in some cases may be harmful |
Level of Evidence | Description |
---|
Level A | Data derived from multiple randomized clinical trials or meta-analyses |
Level B | Data derived from a single randomized trial, or nonrandomized studies |
Level C | Consensus opinion of experts, case studies, or standard of care |
Current Version: nhcvc-master-9e0a1e65-2024-12-09-232944